SCHEMBL4910163

SCHEMBL4910163

Cc1ccc(Oc2ncc(Cl)cc2NS(=O)(=O)c2cc(Cl)c(Cl)s2)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR2 P41597 14/20 0.51
CYP2C9 P11712 5/20 0.48
CCR4 P51679 5/20 0.48
CYP3A4 P08684 4/20 0.48
CYP2C19 P33261 4/20 0.48
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CCR5 P51681 1/20 0.42
PTGES2 Q9H7Z7 1/20 0.42
CCR1 P32246 1/20 0.41
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ACLY P53396 1/20 0.40
KIT P10721 1/20 0.38
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
APEX1 P27695 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4909634 0.88 CCR2 (0.51) CCR2CYP2C9CCR4CYP3A4CYP2C19
SCHEMBL4910002 0.86 CCR2 (0.69) CCR2CYP2C9CCR4CYP3A4CYP2C19
SCHEMBL14006392 0.83 CCR2 (0.55) CCR2CYP2C9CCR4CYP3A4CYP2C19
SCHEMBL4928574 0.81 CCR2 (0.76) CCR2CYP2C9CCR4CYP3A4CYP2C19
SCHEMBL4913044 0.78 CCR2 (0.69) CCR2CYP2C9CCR4CYP3A4CYP2C19
SCHEMBL4901548 0.78 CCR2 (0.54) CCR2CYP2C9CCR4CYP3A4CYP2C19
SCHEMBL10223717 0.78 CCR2 (0.56) CCR2CYP2C9CCR4CYP3A4CYP2C19
SCHEMBL4909963 0.77 CCR2 (0.58) CCR2CYP2C9CCR4CYP3A4CYP2C19
SCHEMBL14006344 0.77 CCR2 (0.55) CCR2CYP2C9CCR4CYP3A4CYP2C19
SCHEMBL4909306 0.77 CCR2 (0.57) CCR2CYP2C9CCR4CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors GLAXO GROUP LIMITED (GB) 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293720-A1 Pyridinyl Sulfonamide Modulators of Chemokine Receptors CCR2, CCR1, CCRL2 CCR2 1/4885CYP2C9 1296/4885CCR4 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.